IL160490A0 - Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections - Google Patents
Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infectionsInfo
- Publication number
- IL160490A0 IL160490A0 IL16049002A IL16049002A IL160490A0 IL 160490 A0 IL160490 A0 IL 160490A0 IL 16049002 A IL16049002 A IL 16049002A IL 16049002 A IL16049002 A IL 16049002A IL 160490 A0 IL160490 A0 IL 160490A0
- Authority
- IL
- Israel
- Prior art keywords
- oxazolidinones
- linezolid
- treatment
- ocular infections
- systematical administration
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 208000001860 Eye Infections Diseases 0.000 title 1
- -1 linezolid Chemical class 0.000 title 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 title 1
- 229960003907 linezolid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32211501P | 2001-09-14 | 2001-09-14 | |
| US32215301P | 2001-09-14 | 2001-09-14 | |
| PCT/US2002/025977 WO2003024528A1 (en) | 2001-09-14 | 2002-09-11 | Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160490A0 true IL160490A0 (en) | 2004-07-25 |
Family
ID=26983274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16049002A IL160490A0 (en) | 2001-09-14 | 2002-09-11 | Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20030069235A1 (enExample) |
| EP (1) | EP1425068A1 (enExample) |
| JP (1) | JP2005507884A (enExample) |
| KR (1) | KR20040035769A (enExample) |
| CN (1) | CN1281211C (enExample) |
| BR (1) | BR0212466A (enExample) |
| CA (1) | CA2460360A1 (enExample) |
| IL (1) | IL160490A0 (enExample) |
| MX (1) | MXPA04002071A (enExample) |
| NZ (1) | NZ531353A (enExample) |
| PL (1) | PL370033A1 (enExample) |
| WO (1) | WO2003024528A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108283622A (zh) * | 2018-04-03 | 2018-07-17 | 广州君博医药科技有限公司 | 一种缓释型利奈唑胺眼用药物及其制备方法 |
| WO2021184339A1 (en) | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| EP1096934B1 (en) * | 1998-07-14 | 2005-09-21 | Pharmacia & Upjohn Company LLC | Oxazolidinones to treat eye infections |
| JP2003529544A (ja) * | 1999-09-13 | 2003-10-07 | インサイト・ビジョン・インコーポレイテッド | 眼感染症の予防たのための局所処置 |
| US6696426B2 (en) * | 2000-08-22 | 2004-02-24 | Pharmacia Corporation | Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
| AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
-
2002
- 2002-09-10 US US10/238,449 patent/US20030069235A1/en not_active Abandoned
- 2002-09-11 WO PCT/US2002/025977 patent/WO2003024528A1/en not_active Ceased
- 2002-09-11 MX MXPA04002071A patent/MXPA04002071A/es active IP Right Grant
- 2002-09-11 IL IL16049002A patent/IL160490A0/xx unknown
- 2002-09-11 CN CNB028154673A patent/CN1281211C/zh not_active Expired - Fee Related
- 2002-09-11 KR KR10-2004-7003679A patent/KR20040035769A/ko not_active Ceased
- 2002-09-11 EP EP02775708A patent/EP1425068A1/en not_active Withdrawn
- 2002-09-11 JP JP2003528621A patent/JP2005507884A/ja active Pending
- 2002-09-11 PL PL02370033A patent/PL370033A1/xx not_active Application Discontinuation
- 2002-09-11 NZ NZ531353A patent/NZ531353A/en unknown
- 2002-09-11 CA CA002460360A patent/CA2460360A1/en not_active Abandoned
- 2002-09-11 BR BR0212466-1A patent/BR0212466A/pt not_active IP Right Cessation
-
2005
- 2005-06-23 US US11/159,897 patent/US20050234052A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005507884A (ja) | 2005-03-24 |
| WO2003024528A1 (en) | 2003-03-27 |
| CN1545428A (zh) | 2004-11-10 |
| US20030069235A1 (en) | 2003-04-10 |
| NZ531353A (en) | 2006-09-29 |
| KR20040035769A (ko) | 2004-04-29 |
| US20050234052A1 (en) | 2005-10-20 |
| CN1281211C (zh) | 2006-10-25 |
| EP1425068A1 (en) | 2004-06-09 |
| CA2460360A1 (en) | 2003-03-27 |
| HK1068564A1 (en) | 2005-04-29 |
| BR0212466A (pt) | 2004-10-19 |
| PL370033A1 (en) | 2005-05-16 |
| MXPA04002071A (es) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0125222D0 (en) | Composition for the treatment of microbial infections | |
| AP2004003002A0 (en) | azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease. | |
| AP2006003514A0 (en) | Piperazine derivatives for the treatment of HIV infections. | |
| SI1427711T1 (sl) | Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva | |
| MXPA03006775A (es) | Formulacion farmaceutica. | |
| MXPA03007641A (es) | Formulacion farmaceutica. | |
| NO20040671D0 (no) | Emballasje for myke, engangs-kontaktlinser. | |
| ES2186550A1 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
| HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
| DE60203537D1 (de) | 5ht1-rezeptoragonist enthaltendes arzneimittel | |
| MXPA02010952A (es) | Composicion reductora para el tratamiento de las fibras queratinicas que comprende silicona aminada particular. | |
| DK1301207T3 (da) | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin | |
| ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
| NO20054070D0 (no) | 4-[(2,4-diklor-5-metoksyfenyl)amino]-6-alkoksy-3-kinol inkarbonitriler for behandling av isjemisk skade. | |
| BR0311874A (pt) | Uso de nefopam para o tratamento de náusea ou emese | |
| MXPA03006958A (es) | Composicion para administracion rectal de farmaco antibacterial de oxazolidinona. | |
| SI1434588T1 (sl) | 2-(amino-3,4-diokso-1ciklobuten-1-il)amino alkil - kislinski derivati za zdravljenje bolečine | |
| AU2003278791A1 (en) | Antimicrobial (3.1.0) bicyclic oxazolidinone derivatives | |
| AU2003291886A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
| MXPA03009194A (es) | DERIVADOS DE HETEROCICLOS DE 5 MIEMBROS, SU PREPARACIoN Y SU APLICACIoN COMO MEDICAMENTOS. | |
| ITGE20020050A0 (it) | Procedimento per il trattamento di filati mediante agugliatura. | |
| PL370033A1 (en) | Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections | |
| NO20054034D0 (no) | Fremgangsmate for behandling av hypotyroidisme. | |
| DK1459748T3 (da) | (S,S)-reboxetin til behandling af perifer neuropati | |
| GB0212790D0 (en) | Medicament for the treatment of diabetes |